Citation Impact
Citing Papers
Alcohol use disorders and mortality: a systematic review and meta‐analysis
2013
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis
2008
Burden of liver diseases in the world
2018 Standout
Hepatitis C Virus Infection Epidemiology among People Who Inject Drugs in Europe: A Systematic Review of Data for Scaling Up Treatment and Prevention
2014
Randomized trial comparing pegylated interferon α‐2b versus pegylated interferon α‐2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients†
2008
Documented rapid course of hepatic fibrosis between two biopsies in patients coinfected by HIV and HCV despite high CD4 cell count
2007
Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses
2010 StandoutNobel
Necroptosis in the Pathophysiology of Disease
2019
Genetics and genomics of alcohol sensitivity
2014
Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?
2005
HIV coinfection shortens the survival of patients with hepatitis C virus‐related decompensated cirrhosis†
2005
Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs
2013
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Expression of inhibitory markers is increased on effector memory T cells during hepatitis C virus/HIV coinfection as compared to hepatitis C virus or HIV monoinfection
2013
Factors influencing adherence in Hepatitis-C infected patients: a systematic review
2014
Management of Hepatocellular Carcinoma *
2005 Standout
Effect of Human Immunodeficiency Virus and Antiretrovirals on Outcomes of Hepatitis C: A Systematic Review From an Epidemiologic Perspective
2007
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Role of Liver Biopsy in the Evaluation of Hepatitis C Virus Infection in HIV Coinfection
2005
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
2006 Standout
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Pegylated Interferon Alfa-2b vs Standard Interferon Alfa-2b, Plus Ribavirin, for Chronic Hepatitis C in HIV-Infected Patients<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2004
Dispensable roles of Gsdmd and Ripk3 in sustaining IL-1β production and chronic inflammation in Th17-mediated autoimmune arthritis
2021 StandoutNobel
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4
2015 StandoutNobel
Plasma Levels, Safety, and 60-Week Efficacy of a Once-Daily Double-Boosted Protease Inhibitor Regimen of Atazanavir, Saquinavir, and Ritonavir
2008
Mortality in Mental Disorders and Global Disease Burden Implications
2015 Standout
Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
2021
Epidemiology ofDSM-5Alcohol Use Disorder
2015 Standout
Hepatitis C virus NS 3/4A quasispecies diversity in acute hepatitis C infection in HIV ‐1 co‐infected patients
2014
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
mice: Multivariate Imputation by Chained Equations inR
2011 Standout
Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
2016 StandoutNobel
The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
2014 StandoutNobel
Works of Daniel Fuster being referenced
Advanced Liver Fibrosis in HIV/HCV-Coinfected Patients on Antiretroviral Therapy
2004
Poor Response to Hepatitis C Virus (HCV) Therapy in HIV- and HCV-Coinfected Patients Is Not Due to Lower Adherence to Treatment
2006
Baseline Factors associated with Haematological Toxicity that Leads to a Dosage Reduction of Pegylated Interferon-α2a and Ribavirin in HIV- and HCV-Coinfected Patients on HCV Antiviral Therapy
2005
Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co‐infected patients
2003
Review of atazanavir: a novel HIV protease inhibitor
2005
Early HCV dynamics on Peg-interferon and ribavirin in HIV/HCV co-infection
2004
Estimated Liver Fibrosis and its Impact on All-Cause Mortality of HCV-Monoinfected and HCV/HIV-Coinfected Drug Users
2011
Folate deficiency in patients seeking treatment of alcohol use disorder
2017
Short communication. Baseline factors associated with haematological toxicity that leads to a dosage reduction of pegylated interferon-alpha2a and ribavirin in HIV- and HCV-coinfected patients on HCV antiviral therapy.
2005
Impact of Medical Comorbidity and Risk of Death in 680 Patients with Alcohol Use Disorders
2013
Alcohol Use in Patients with Chronic Liver Disease
2018